Pilocarpine Hydrochloride USP for Compounding is an active pharmaceutical ingredient used to formulate customized medications for the treatment of conditions related to dry mouth and certain eye disorders. As a miotic agent, pilocarpine stimulates the secretion of saliva, making it effective in managing xerostomia (dry mouth), often resulting from conditions like Sjögren's syndrome or as a side effect of radiation therapy. In ophthalmology, pilocarpine is used to reduce intraocular pressure in patients with glaucoma by increasing fluid drainage from the eye. Compounded formulations allow for personalized dosing and administration forms tailored to specific patient needs.
Ships in 2-4 business days.
Pilocarpine hydrochloride USP is a drug and active pharmaceutical ingredient (API) used to treat a variety of medical conditions, such as dry mouth, glaucoma, and Sjogren's syndrome. It belongs to the group of drugs known as cholinergic agonists, which stimulate the release of acetylcholine in various parts of the body. This results in the activation of different glands and muscles, leading to increased saliva and tear production, as well as constriction of the pupils in the eyes.
Pilocarpine hydrochloride USP is a synthetic compound derived from the leaf extracts of the South American shrub Pilocarpus jaborandi. It is available in various forms, including tablets, eye drops, and topical gels.
In addition to its therapeutic effects, pilocarpine hydrochloride USP also has potential side effects, such as sweating, dizziness, and blurred vision. It is important to only use this drug under medical supervision and to follow the prescribed dosage instructions.
Pilocarpine Hydrochloride USP for compounding is a drug used in the preparation of individualized medications by pharmacists, known as compounded medications. Pilocarpine Hydrochloride is a cholinergic agonist medication that is used for its ability to stimulate the body's parasympathetic nervous system. It is commonly used to treat conditions such as dry mouth in patients with Sjögren's syndrome and in the formulation of eye drops for the treatment of glaucoma.
CAS Number: 54-71-7
Property: Light Sensitive | Hazardous Material | Hygroscopic
Skip to content
